Transmembrane BAX inhibitor motif-containing 1 (TMBIM1), which is a multivesicular body (MVB) regulator, protected against NAFLD in mice and monkeys by targeting the lysosomal degradation of TLR4 [87]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.